NewEdge Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $703K | Buy |
41,970
+7,384
| +21% | +$124K | ﹤0.01% | 1491 |
|
|
2025
Q1 | $532K | Sell |
34,586
-896
| -3% | -$13.8K | ﹤0.01% | 1552 |
|
|
2024
Q4 | $782K | Buy |
35,482
+3,983
| +13% | +$87.8K | ﹤0.01% | 1295 |
|
|
2024
Q3 | $568K | Sell |
31,499
-42
| -0.1% | -$757 | ﹤0.01% | 1399 |
|
|
2024
Q2 | $513K | Buy |
31,541
+21,484
| +214% | +$349K | ﹤0.01% | 1412 |
|
|
2024
Q1 | $142K | Buy |
10,057
+7,195
| +251% | +$102K | ﹤0.01% | 1944 |
|
|
2023
Q4 | $29.9K | Buy |
2,862
+113
| +4% | +$1.18K | ﹤0.01% | 2412 |
|
|
2023
Q3 | $28K | Sell |
2,749
-10,876
| -80% | -$111K | ﹤0.01% | 2281 |
|
|
2023
Q2 | $103K | Buy |
13,625
+1,687
| +14% | +$12.7K | ﹤0.01% | 1843 |
|
|
2023
Q1 | $106K | Buy |
11,938
+5,930
| +99% | +$52.5K | ﹤0.01% | 1740 |
|
|
2022
Q4 | $11.8K | Buy |
+6,008
| New | +$11.8K | ﹤0.01% | 2318 |
|
|
2017
Q3 | – | Sell |
-816
| Closed | -$25.4K | – | 1043 |
|
|
2017
Q2 | $25.4K | Buy |
+816
| New | +$25.4K | ﹤0.01% | 667 |
|